chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from the authors in a published literature article, regarding 5 (also reported as 17% of 28 patients) adolescent or young adult patients of unknown age and gender with perinatally acquired human immunodeficiency virus (PAH). On an unknown date, the patients were vaccinated with a dose of MMR (Manufacturer unknown) (Lot number, expiration date, strength, dose and frequency were not provided). Concomitant medication was not reported. On an unknown date, despite appropriate prior vaccination, the patient experienced measles non-immunity which was defined as IgG titers < 120 miU by plaque reduction neutralization (PRN) assay and < 0.70 IU by measles enzyme immunoassay (EIA) (vaccination failure and seroconversion test negative). The outcome of vaccination failure and seroconversion test negative was unknown at the time of the report. The reporter considered vaccination failure and seroconversion test negative to be related to MMR (manufacturer unknown). This is one of several reports from the same source (MARRS# 1601USA010845, 1601USA010935, 1601USA010936). Additional information has been requested.
This is a spontaneous report from a contactable consumer (the patient). A 42-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number not provided), via an unspecified route of administration in the left arm on 13Apr2021 10:45 (at the age of 42-years-old) as a single dose for COVID-19 immunization. The patient's medical history included: tonsils removed at age 6 and heart rate at rest low. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medications included: acetylsalicylic acid/ caffeine, paracetamol (EXCEDRIN EXTRA STRENGTH) and cetirizine hydrochloride (ZYRTEC), both taken for an unspecified indication, start and stop date were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number not provided), via an unspecified route of administration in the left arm on 23Mar2021 11:15 (at the age of 42-years-old) as a single dose for COVID-19 immunization. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient stated he fainted the morning after receiving the shot on 14Apr2021 06:00. No treatment was received for the event. The outcome of fainted was recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19. Information about lot/batch number has been requested.
9/2/2000, C/O feeling hot (temp 101) Gave extra strength Tylenol. Put cold rags on then c/o neck stiffness. Complaint of sensitive, nausea and vomited x 2. Temperature 103, felt lethargy
Full body aches, chills, headaches, ear pain,  low fever, high resting heart (>120) for 12+ hours
Very fluish- aches, pains, very bad headache, couldn't get out of bed for 36 hours.  After 48 hours I am just very tired and having sporadic shooting pains in my head.
Expired dose given; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 4-year-old male patient who received DTPa (Infanrix) (batch number 7EC55, expiry date 29-APR-2023) for prophylaxis.   On 23-MAY-2023, the patient received Infanrix. On 23-MAY-2023, an unknown time after receiving Infanrix, the patient experienced expired vaccine used (Verbatim: Expired dose given). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 24-May-2023 The medical assistant called to report that an expired dose of Infanrix was accidentally given, wished to know how to proceed.  The information about vaccine, patient and event collected. The reporter consented to follow up.  The vaccine administration facility was the same as primary reporter. The patient was administered an expired dose of Infanrix, which led to expired vaccine used.
Strong seasonal allergy symptoms: itchy eyes, sneezing, runny nose.  Ongoing one year later, poorly controlled with daily 10 mg cetirizine.
Pain down left arm at site of injection, pains in lower back, physical therapy twice following week, pains got worse in back, steroid injection given, following week off work for a week as could not walk. MRI done Friday 10/24/2014, bulging discs, inflammation, given steroids for 6 days, helped, now pain is in piriformis muscle, down left side from upper arm to left ankle, PT twice a week, stiffness upon getting up from seat, pain lying down.
No adverse event; Monovalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) in a 36-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 11-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients).    Concomitant medications were not reported.  Total 51 doses from Lot AS7140C Bivalent doses were administered after the BUD to patients. Treatment medications were not reported.
10/25/2009 10 PM - Headache, diarrhea, nausea - 10/21/09 Redness to injection site - 10/22/09 4 cm circumference redness to injection site - Pain.
I experienced on Wednesday night the coarseness and a bit of a scratchy throat. We were supposed to travel that weekend, so I took the home test and it came back negative. I thought it would be laryngitis or allergies. But the next morning it was bad, so I called the doctor and we did a strep test. We talked about whether to do another COVID test, and to be on the safe side, we did another test. I left and they would call me. Probably less than 30 minutes later, they called and said it was positive. They prescribed PAXLOVID. I took 3 tablets in the morning and 3 tablets in the evening. Two of the tablets were Nirmatrelvir and the last one was Ritonavir. The one side effect they did mention was that it would give you a bad metal taste in your mouth The sore throat went away in 24 hours. A little bit of a cough at night, but it's not a productive cough. Tiredness is still continuing possibly due to the cough because it will wake me up at night.
Extreme fatigue, dizziness, underarm has a mass or swollen gland of arm that received injection. It?s extremely painful into left breast. All I?ve done is sleep.
I was outside deer hunting and I usually hunt all day. While hunting my feet got cold and tingly at the bottom. Didn't think about it. 3 days later it happened again and I called my dr. to see him because I didn't know if it was related to my diabetes. I saw the doctor on 11/23. He checked my feet and sent my bloodwork. The doctor placed me on 2 medications, amlodipine besylate and vitamin B12 dosage to help bring up my Vitamin B12 in my blood.
No adverse reaction at this time. Vaccination was given approximately one hour and twenty minutes after the beyond use time.
Waking up screaming every hour maybe more. Extremely fussy and not really able to make feel better. Loss of appetite.
High heart rate; Chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (High heart rate), CHILLS (Chills) and PYREXIA (fever) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced HEART RATE INCREASED (High heart rate), CHILLS (Chills) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency; ACETAMINOPHEN for Adverse event, at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ASPIRIN ANALGESIC) for Adverse event, at an unspecified dose and frequency. At the time of the report, HEART RATE INCREASED (High heart rate), CHILLS (Chills) and PYREXIA (fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
n/v, tremors, fatigue, fever, chills;abd pain, diarrhea, mood swings, hair loss;
Adverse event: PT reported feeling SOB and "a little lightheaded" (continuing after he stood up) post vaccination. PT also reports he ate a small breakfast (half a banana) and worked out before vaccination.  Treatment: EMS summoned, assessed PT. Obtained vital signs (108/68 BP, HR 50, SPO2 100%). VS obtained 3 minutes later ( BP 106 palp, HR 46, SPO2 100%).  Provided juice x2. PT advised to eat lunch, let his primary care provider that his HR remained low (48-52) . Outcome: PT reports feeling better after juice, medically cleared by EMS, escorted to private vehicle by EMS, brother will drive him home.
Patient came into the clinic today to report the following:  He states he received his first Moderna injection on 1-26-2021 and the second on 2-23-2021.  One week after the second shot he began to have severe joint pain in his hands, knees and shoulder.  2 nd week after the last shot he had the shingles.  The 3 rd week after the shot he was diagnosed with blood clots in both lungs and was hospitalized for 3 days.  They gave him blood thinner in the hospital and sent him home with more to take.  States as of today (6-4-2021) he is still having problems with fatigue and swelling/ pain in his hands, knees and shoulders.
Patient came to vaccination site to receive 2nd primary Pfizer vaccination. He was given a Pediatric dose at 0.2ml, despite being over 12 years old. There was a language barrier that aided in this medication error. Troubleshooting: Found in data mining; reviewed what a 12+ year old patient should get for a vaccination, reviewed system checks on how to make sure this child receives the correct dose. Found in data mining.
Information has been received from a county health registered nurse concerning a patient (age and gender not reported) who in 2007 was vaccinated intramuscularly with Pneumovax 23.  Subsequently, the patient developed a local site reaction post vaccination. The patient sought unspecified medical attention.  At the time of this report, the outcome of the event was unknown.  Additional information has been requested.
Lymph nodes in left underarm became very swollen and painful. The pain lasted 4 days. Pain relievers and warm compresses did very little to relieve the pain.
Right arm around the wrist is puffy - during the day it went bigger and bigger; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Right arm around the wrist is puffy - during the day it went bigger and bigger) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced JOINT SWELLING (Right arm around the wrist is puffy - during the day it went bigger and bigger). The patient was treated with IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, JOINT SWELLING (Right arm around the wrist is puffy - during the day it went bigger and bigger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.
My arm was mildly sore at  the injection site for about 36 hours.  2/18/21 (Thurs.) ? In the morning (only) there were rashes on my L arm, my neck and my back. While I have had a few itchy pimple areas for several weeks, and am generally sensitive to everything, this is not the same. It is also not the same as the transient flushing that I have in my face for a few minutes each morning after I take 500 mg. of Niacin.   2/23/21 (Tues.) ? At 8:30 a.m. I had flushing (not quite a noticeable rash) on my back, face, shoulders and both arms, esp. the L arm. (This was 20-30 minutes after I had taken Niacin, but the brief flushing, just in my face, resulting from the Niacin was long gone before these other rashes/flushing occurred.) Later, after 9:00 a.m., there was warmth and itching on my lower back. At 9:45 a.m. I felt flushing in my thighs and lower legs. At 10:00 a.m. there was an actual red rash on my chest and stomach. This all seems unusual for one week after the CoVID-19 shot.     2/27/21 (Sat.) ? Starting at 9:50 a.m. (30 minutes after taking 500 mg. of Niacin, which usually results in immediate flushing of my face, for only a few minutes at most), I had flushing and itching, and a slight rash, on my upper chest and upper back. After a few minutes the flushing and itching spread to my lower back, and my upper arms; my upper arms had a noticeable rash, which then spread down to my hands. In the next few minutes the flushing, itching and rash extended to my upper inner thighs and lower back (although I am only assuming, based on the feeling of flushing and itching, that my lower back had a rash, since I couldn?t see there). Over the next several minutes the itching and rash extended to the front and side of my thighs, down to my knees. The rash then extended, to a lesser extent, down to my ankles. As of 10:50 a.m. I still have this flushing, itching and/or rash in all the places mentioned, although it has started to decrease. This was mostly gone by 12:00 p.m. Other than 4 days ago, I don?t think I have previously experienced this generalized reaction in my 73 years.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and genders. The reporter stated that, on an unspecified date, an unknown number of doses of LIQUID PEDVAXHIB, (dose, lot#, expiration dates not provided) that were stored at 48 degrees F for 20 minutes, then exposed to 47 degrees for 9 minutes have been administered. No adverse effects were reported.   Follow up information had been received on 22-JUL-2014 from a receptionist. The reporter stated that there were two different lot numbers of LIQUID PEDVAXHIB that were included in the temperature excursion: Lot # J016188, expiration date: 02-OCT-2016 and lot # J015437, expiration date: 09-OCT-2016. The receptionist did not have any additional information to share.  Follow-up information has been received from the registered nurse who provided patients details. This report refers to a 22 months old patient of unknown gender. On 04-JUN-2014 the patient was vaccinated with a dose of LIQUID PEDVAXHIB (dose and route were not reported), lot#J016188, expiration date: 02-OCT-2016 that was improperly stored. No adverse effects were reported.  This is one of several reports received from the same reporter. Additional information is not expected.
The patient came in for her second dose of the Moderna vaccine.   When inputting her information, the submission was rejected due to a second fill already received.  One of the technician's had a vaccination card for the patient who received the first dose of Moderna @our location on 05/14/2021. When the technician printed the report, it showed that a COVID vaccine was administered for the patient on 04/22/2021. When the technician asked the patient about the date of 04/22/2021, she presented a second card with information regarding a Pfizer dose administered @another location on 04/22/2021. The pharmacist immediately called the CDC and they instructed him not to administer another dose and to report the incident to VAERS.
covid 19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (covid 19) in a 74-year-old male patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 prophylaxis: Moderna Covid-19 vaccine on 24-Dec-2020 and Moderna Covid-19 vaccine on 21-Jan-2021. Past adverse reactions to the above products included No adverse event with Moderna Covid-19 vaccine and Moderna Covid-19 vaccine.    In October 2022, the patient received third dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On 03-Sep-2023, the patient experienced COVID-19 (covid 19). At the time of the report, COVID-19 (covid 19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Sep-2023, SARS-CoV-2 test: Positive. On 04-Sep-2023, SARS-CoV-2 test: Negative. On 05-Sep-2023, SARS-CoV-2 test: Negative.     For SPIKEVAX NOS (SPIKEVAX NOS) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication not reported.   The patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Treatment medication not reported.
Woke up with arm feeling like a brick, sore throat, wheezing, cough, unsteady on feet, cough and wheezing persisted, no voice. Headache developed within a day
Mild chest pain/ Moderate chest pain; headache; body ache; chills; fever; lingering cough; Booster; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 44 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 09Dec2021 16:30 (Lot number: FJ8757) at the age of 44 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: GABAPENTIN; DEPAKOTE. Vaccination history included: Bnt162b2 (Dose 2, on Left arm, Lot No: EW0182 ), administration date: 05May2021, when the patient was 43 years old, for COVID-19 immunization; Bnt162b2 (Dose 2, on Left arm, Lot No: EW0164, ), administration date: 15Apr2021, when the patient was 43 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 09Dec2021 16:30, outcome "unknown", described as "Booster "; CHEST PAIN (non-serious) with onset 09Dec2021 16:45, outcome "recovering", described as "Mild chest pain/ Moderate chest pain"; HEADACHE (non-serious) with onset 09Dec2021 16:45, outcome "recovering", described as "headache"; PAIN (non-serious) with onset 09Dec2021 16:45, outcome "recovering", described as "body ache"; CHILLS (non-serious) with onset 09Dec2021 16:45, outcome "recovering", described as "chills"; PYREXIA (non-serious) with onset 09Dec2021 16:45, outcome "recovered" (11Dec2021 04:45), described as "fever"; COUGH (non-serious) with onset 09Dec2021 16:45, outcome "recovering", described as "lingering cough". Therapeutic measures were not taken as a result of chest pain, headache, pain, chills, pyrexia, cough.  Additional information: No known allergies were reported.  The patient had not received any other vaccine in four weeks prior to vaccination. The patient had mild chest pain immediately after, headache, body ache, chills, fever for 36 hrs then moderate chest pain and lingering cough and headache. It was reported that the patient was not diagnosed with SARS-CoV-2 infection before or after vaccination.  No follow-up attempts are possible. No further information is expected.
Day 1 pain under left shoulder joint. 3 days later stiffness in shoulder.  Next I could not raise left arm then both arm painful to raise. Left elbow shooting pain. Left hand tingling sensations.  Left leg aching  in thigh . A month later symptoms are still active. Painful  in neck and elbow  of left  side. Very unusual for me to be so tired. I'm so tired and had to take days off work to be in bed.
Itch on webbing of fingers (between 3rd and 4th), severe fatigue, severe headache. Missed work due to side effects
Vaccine administered came from vial that was kept in fridge longer than manufacture recommended storage date. Patient did not return our multiple calls to inform them of the expire vaccine that they received.  The patient did not call back in any capacity to complain about any adverse events. The manufacture informed us via written statement that patients "maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration." Revaccination was not advised.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a 74-year-old female patient who received SHINGRIX (batch number 5737X, expiry date 23rd January 2021) for prophylaxis. On 25th June 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 26th June 2018, 1 days after receiving SHINGRIX, the patient experienced injection site swelling and injection site erythema. On an unknown date, the outcome of the injection site swelling was recovering/resolving and the outcome of the injection site erythema was not recovered/not resolved. It was unknown if the reporter considered the injection site swelling and injection site erythema to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX vaccine on an unknown upper arm. The pharmacist reported that one of the patient complained that her arm was swollen. The pharmacist believed that symptoms started the day after the SHINGRIX injection. The pharmacist said that it was a large part of her upper arm where she received the injection, not just the site of the injection. The pharmacist was unsure if the patient was still having the symptoms. The pharmacist saw the patient a few days before the reporting date, and the swelling went down a lot but her arm was still red.
The site of the injection area was red, warm to touch and slightly swollen/inflamed. The patient mention that she has a burning sensation upon administering this vaccine. I massaged the area after the injection and told her to take Tylenol or ibuprofen. The patient came back on Sunday, July 22nd, 2018 and the area of the injection was still red and warm to touch. She mention she only took ibuprofen once a day so I mentioned to her that she had to take ibuprofen around the clock to decrease the inflammation and swollenness, ice the area, use hydrocortisone if it is itchy, and take a Benadryl. The patient came on Tuesday, July 24th, and the swelling and inflammation went down. The ibuprofen and icing suggestion worked and we gave her a tube of hydrocortisone cream since she was only complaining about the itching around the area of injection. She was told to take Benadryl just in case anything else happen.
Hives - over all of body starting with shoulders and going to neck, torso, arms, legs.
pt devel a fever of 101 & swollen, red arm; observed & got better;